Cambridge Investment Research Advisors’s iShares iBonds Dec 2020 Term Corporate ETF IBDL Stock Holding History
Bought
Maintained
Sold
Other funds holding IBDL
Cambridge Investment Research Advisors's IBDL Position: Q4 2020 in Review
Cambridge Investment Research Advisors sold out of iShares iBonds Dec 2020 Term Corporate ETF (IBDL) in Q4 2020, closing a stake of 102,951 shares — an estimated $2.6M sold.
Cambridge Investment Research Advisors first reported a position in IBDL in Q2 2017 and held it in 9 quarters. The position peaked at $2.6M in Q3 2020. 1 fund tracked by Wall St. Rank holds IBDL as of Q4 2020.
- Cambridge Investment Research Advisors reported no remaining iShares iBonds Dec 2020 Term Corporate ETF position as of Q4 2020 after selling out during the quarter.
- Cambridge Investment Research Advisors sold 102,951 iShares iBonds Dec 2020 Term Corporate ETF shares in Q4 2020, an estimated $2.6M.
- Cambridge Investment Research Advisors first reported a position in iShares iBonds Dec 2020 Term Corporate ETF in Q2 2017 and held it in 9 quarters.
- Cambridge Investment Research Advisors's iShares iBonds Dec 2020 Term Corporate ETF position peaked at $2.6M in Q3 2020.
- 1 fund tracked by Wall St. Rank held iShares iBonds Dec 2020 Term Corporate ETF as of Q4 2020.
Based on Cambridge Investment Research Advisors's 13F filing for Q4 2020, filed 4 Feb 2021.